logo

For the Inventor, By the Inventor

West Chester, OH, United States of America

Nelsen L Lentz

This inventor holds 10 USPTO granted patents, plus 8 CIPO patents. Top assignees: Merrell Dow Pharmaceuticals, Merrell Pharmaceuticals, Inc.. Active years: 1988-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nelsen L Lentz. Retrieved from https://idiyas.com/inventor/nelsen-l-lentz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 100.0


Average Co-Inventor Count = 2.3

ph-index = 4

Forward Citations = 40(Granted Patents)


Location History:

  • Indianapolis, IN (US) (1988)
  • West Chester, OH (US) (1991 - 1998)

Company Filing History:

goldMedal9 out of 455 
 
Merrell Dow Pharmaceuticals
 patents
silverMedal1 out of 194 
 
Merrell Pharmaceuticals, Inc.
 patents

Years Active: 1988-1998

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 5734052 - 8-substituted xanthines as selective adenosine receptor agents (1998-03-31),
2. 5426101 - 2-substituted adenosines with A-2 receptor affinity (1995-06-20),
3. 5391739 - Selective adenosine receptor agents (1995-02-21),
4. 5359131 - Sulfonic acid derivatives in the treatment of viral diseases (1994-10-25),
5. 5329007 - Selective adenosine receptor agents (1994-07-12),
6. 5256650 - Selective adenosine receptor agents (1993-10-26),
7. 5208240 - 8-substituted purines as selective adenosine receptor agents (1993-05-04),
8. 5086176 - Tricyclic fused adenine derivatives (1992-02-04),
9. 5064947 - Selective adenosine reseptor compounds (1991-11-12),
10. 4748274 - 4-hydroxy-4-(substituted alkenyl)cyclohexanecarboxylic acids (1988-05-31),

Title: Nelsen L Lentz: Innovator in Adenosine Receptor Agents

Introduction

Nelsen L Lentz is a prominent inventor based in West Chester, OH (US). He has made significant contributions to the field of pharmacology, particularly in the development of selective adenosine receptor agents. With a total of 10 patents to his name, Lentz has established himself as a key figure in the pharmaceutical industry.

Latest Patents

Among his latest patents are innovative compounds such as 8-substituted xanthines and 2-substituted adenosines with A-2 receptor affinity. One notable compound is (R)-2-[(phenylisopropyl)amino]adenosine. This compound exhibits selectivity between the A-1 and A-2 adenosine receptors that is approximately two orders of magnitude greater than its diastereoisomer. The implications of this compound are significant, as it is useful for lowering blood pressure.

Career Highlights

Lentz has worked with reputable companies in the pharmaceutical sector, including Merrell Dow Pharmaceuticals and Merrell Pharmaceuticals, Inc. His work has contributed to advancements in drug development and therapeutic applications.

Collaborations

Throughout his career, Lentz has collaborated with notable professionals in the field, including Norton P Peet and Mark W Dudley. These collaborations have further enhanced his research and development efforts.

Conclusion

Nelsen L Lentz is a distinguished inventor whose work in adenosine receptor agents has had a profound impact on pharmacology. His innovative patents and collaborations reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…